TIB-196U266B1 人外周淋巴细胞

公司名称：
参考价：
更新时间：
所在地：
生产地址：
浏览次数：

桑戈国际贸易（上海）有限公司
18元（具体成交价以合同协议为准）
2021-02-08 15:41:34
上海市
美国
765

【简单介绍】

品牌	其他品牌	供货周期	一周
应用领域	医疗卫生,环保,生物产业,石油

TIB-196 U266B1 人外周淋巴细胞
ATCC® Number: TIB-196™ Price:
Designations: U266B1 [U266]
Depositors: NK Nilsson
Isotype: IgE; lambda light chain
Biosafety Level: 1

【详细说明】

TIB-196 U266B1 人外周淋巴细胞

ATCC^® Number:

TIB-196™

Designations:	U266B1 [U266]
Depositors:	NK Nilsson
Isotype:	IgE; lambda light chain
Biosafety Level:	1
Shipped:	frozen
Medium & Serum:	See Propagation
Growth Properties:	suspension
Organism:	Homo sapiens （human）
Morphology:	lymphoblast
Source:	Organ: peripheral blood Disease: myeloma; plasmacytoma Cell Type: B lymphocyte;
Cellular Products:	immunoglobulin; monoclonal antibody; interleukin 6 （interleukin-6, IL-6）
Permits/Forms:	In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
TIB-196 U266B1 人外周淋巴细胞
Applications:	transfection host （Nucleofection technology from Lonza）
DNA Profile （STR）:	Amelogenin: X,Y CSF1PO: 12,13 D13S317: 12 D16S539: 10 D5S818: 11,12 D7S820: 11,12 THO1: 5,7 TPOX: 8 vWA: 17
Age:	53 years adult
Gender:	male
Comments:	U266 cells have been reported to produce human IL-6.
Propagation:	ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 15%.
Subculturing:	Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 3 x 10 exp5 cells/ml and maintain between 1 x 10 exp5 and 1 x 10 exp6 cells/ml.
Preservation:	culture medium 95%; DMSO, 5%
Related Products:	Recommended medium （without the additional supplements or serum described under ATCC Medium）:ATCC 30-2001 recommended serum:ATCC 30-2020
References:	1180: Nilsson K, et al. Established immunoglobulin producing myeloma （IgE） and lymphoblastoid （IgG） cell lines from an IgE myeloma patient. Clin. Exp. Immunol. 7: 477-489, 1970. PubMed: 4097745 22377: Kawano M, et al. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332: 83-85, 1988. PubMed: 3258060 32396: Kolanus W, et al. alphaLbeta2 integrin/LFA-1 binding to ICAM-1 induced by cytohesin-1 a cytoplasmic regulatory molecule. Cell 86: 233-242, 1996. PubMed: 8706128

TIB-196


留言框
感兴趣的产品：	*
留言内容：
您的姓名：	*
您的单位：
联系电话：	*
微信：
常用邮箱：
详细地址：
省份：	*
验证码：	* = 请输入计算结果（填写阿拉伯数字），如：三加四=7